Quick viewing(Text Mode)

Homogeneity and Stability in Drinking Water of Oral Nonsteroidal Anti-Inflammatory Drugs Labelled for Swine in Europe­

Homogeneity and Stability in Drinking Water of Oral Nonsteroidal Anti-Inflammatory Drugs Labelled for Swine in Europe­

Original ­research Peer ­reviewed Homogeneity and stability in drinking water of oral nonsteroidal anti-inflammatory drugs labelled for swine in Europe­

Irene Mayós, PhD; Jaume Bosch, DVM; Emili Fadurdo, BS; Josep Homedes, DVM, P­ hD

Summary at three standard depths in the tank (high, Implications: When NSAIDs in drinking- Objectives: To verify the stability and homo- medium, and low) at 5 minutes, 12 hours, water tanks are used to treat farm animals, geneity in drinking water of five nonsteroidal and 24 hours post ­mixing. variability in dose may occur if the water is not adequately stirred after product addi- anti-inflammatory drugs (NSAIDs) labeled Results: No time-related statistically tion. Lack of homogeneity may produce for pigs in Europe, including oral solutions of significant differences were observed in overdose or underdose, thereby increasing ketoprofen (300 mg per mL) and active-principle concentrations. However, the risk of adverse events and violative (200 mg per mL) and soluble powders of significant differences were detected at dif- residues in the carcasses or the possibility of 100%, paracetamol (200 mg ferent sampling depths for sodium salicylate lack of efficacy, respectively. This situation is per g), and acetylsalicylic acid 100%, under and paracetamol powder and solution. Some more evident when the added product is a field ­conditions. variability was observed for acetylsalicylic soluble powder rather than a ­solution. Materials and methods: A solution of each acid, but differences were not statistically product was prepared according to label significant. Concentrations obtained at Keywords: swine, ketoprofen, paracetamol, instructions in a 300-L farm tank, without all time points and sampling depths for , drinking water ­treatment ketoprofen approached calculated values, stirring. Active ingredient concentrations Received: January 12, 2012 indicating better homogeneity and stability were determined by high-performance liquid Accepted: May 29. 2012 chromatography on three samples collected in drinking w­ ater.

Resumen - Homogeneidad y estabilidad de instrucciones de la etiqueta. Se determinó la traciones obtenidas en todos los tiempos y medicamentos antiinflamatorios no estero- concentración de ingrediente activo a través profundidades para ketoprofen se aproxima- idales orales en el agua de bebida autoriza- de la cromatografía líquida de alta resolución ron a los valores calculados, indicando una dos para cerdos en Europa en tres muestras recolectadas a tres profun- mejor homogeneidad y estabilidad en el agua didades estándares (alta, media, y baja) en el de bebida. Objetivos: Verificar, bajo condiciones de tanque a los 5 minutos, 12 horas, y 24 horas campo, la estabilidad y homogeneidad en el Implicaciones: Cuando los NSAIDs se post mezcla. agua de bebida de cinco medicamentos anti- utilizan para tratar animales de granja en inflamatorios no esteroidales (NSAIDs por Resultados: No se observaron diferencias los tanques de agua de bebida puede haber sus siglas en inglés) autorizados para cerdos estadísticamente significativas en las concen- variabilidad en la dosis si el agua no se agita en Europa, incluyendo soluciones orales de traciones de principio activo con relación adecuadamente después de la adición del ketoprofen (300 mg por mL) y paracetamol al tiempo de muestreo. Sin embargo, se producto. La falta de homogeneidad puede (200 mg por mL) y polvo soluble de silicato detectaron diferencias significativas a dife- producir una sobredosis o una dosis inferior, de sodio 100%, paracetamol (200 mg por g), rentes profundidades en las muestras de incrementando así el riesgo de reacciones y ácido acetilsalicílico 100%. solución y polvo de paracetamol y silicato de adversas y la presencia de residuos no per- sodio. Se observó variabilidad para el ácido mitidos en la canal o la posibilidad de falta Materiales y métodos: En un tanque de acetilsalicílico, pero las diferencias no fueron de eficacia, respectivamente. Esta situación granja de 300 L, se preparó sin agitar una estadísticamente significativas. Las concen- es más evidente cuando el producto se agrega solución de cada producto de acuerdo a las como polvo soluble y no en solución.

IM, JH: Esteve Veterinaria, Laboratorios Dr Esteve SA, Barcelona, ­Spain. Résumé - Homogénéité et stabilité dans JB: Clinobs SL (Estudis Clínics Veterinaris), Banyoles (Girona), ­Spain. l’eau de boisson de médicaments anti- EF: Laboratorio de Diagnóstico General, Barcelona, ­Spain. inflammatoires non-stéroïdiens homo- Corresponding author: Dr Josep Homedes, Esteve Veterinaria, Laboratorios Dr Esteve SA, Avda logués pour les porcs en Europe Mare de Déu de Montserrat, 221, 08041 Barcelona, Spain; Tel: + 34 93 4466318; Fax: + 34 93 446 Objectifs: Vérifier, dans des conditions de 6201: E-mail: ­[email protected]. champs, la stabilité et l’homogénéité dans This article is available online at http://www.aasv.org/shap.html. l’eau de boisson de cinq médicaments anti- Mayós I, Bosch J, Fadurdo E, et al. Homogeneity and stability in drinking water of oral nonsteroidal inflammatoires non-stéroïdiens (AINS) anti-inflammatory drugs labelled for swine in ­Europe. J Swine Health Prod. 2012;20(6):270–275. homologués pour les porcs en Europe, 270 Journal of Swine Health and Production — November and December 2012 incluant des solutions orales de ketoprofène Résultats: Aucune différence statistique- Implications: Lorsque des AINS préparés (300 mg/mL) et de paracetamol (200 mg/ ment significative associée au temps n’a dans des réservoirs d’eau de boisson sont mL) et des poudres solubles de salicylate de été observée dans les concentrations des utilisés pour traiter des animaux de ferme, sodium 100%, de paracetamol (200mg/g) et principes actifs. Toutefois, des différences une variabilité dans la dose peut survenir d’acide acétylsalicilique 100%. significatives furent détectées dans les échan- si l’eau n’est pas brassée adéquatement tillons prélevés à des profondeurs différentes après l’ajout du médicament. Un manque Matériels et méthodes: Une solution de pour le salicylate de sodium et la poudre et d’homogénéité peut entraîner une surdose chaque produit a été préparée dans un réser- la solution de paracetamol. Une certaine ou une sous-dose, augmentant ainsi le risque, voir de ferme de 300 L selon les instructions variabilité fut également observée pour respectivement, de réactions adverses et sur l’étiquette, sans agitation. Les concentra- l’acide acétylsalicylique, mais les différences d’infractions pour résidus dans les carcasses tions d’ingrédient actif ont été déterminées n’étaient pas statistiquement significatives. ou la possibilité d’un manque d’efficacité. par chromatographie liquide à haute per- Les concentrations obtenues à tous les temps Cette situation est plus évidente lorsque le formance sur trois échantillons prélevés à et profondeurs d’échantillonnage pour le produit ajouté est une poudre soluble plutôt trois profondeurs standards dans le réservoir ketoprofène s’approchaient des valeurs cal- qu’une solution. (haute, moyenne, et basse) à des temps de culées, indiquant une meilleure homogénéité 5 minutes, 12 heures, et 24 heures suite à la et stabilité dans l’eau de boisson. préparation du mélange.

rugs are often administered in administration route of drugs from both hours post mixing. All medicated water drinking water to treat large groups a pharmacokinetic and residue viewpoint, samples were frozen at -25°C ± 5.0°C until of various livestock species under which could lead to errors in withdrawal submitted to the analytical laboratory, suit- Dintensive farming conditions. This route of times. Dorr et al5 reported the influence of ably packaged in dry ice, for determination administration is less labor intensive and water flow when tetracycline hydrochloride of active-ingredient ­concentrations. less stressful for the animals than individual is administered by this route in pig farms, Firstly, in order to facilitate its dissolu- administration by the parenteral route, and its subsequent therapeutic effect. tion and following normal field practice, a which would also prove unfeasible in com- Toutain and Lees2 and Santos et al6 also predilution of each product was prepared mercial poultry facilities1 and many swine related the variability of this administration by adding the total dose to be administered finishing farms. However, when products route to the possible onset of resistance (in a final water volume of 300 L) to 10 L are administered in drinking water, the dose if antibiotic underdose were to occur. In of water in a plastic bucket. This predilution ingested by each animal may vary because addition to these factors, other sources of was poured directly into a previously cali- of differences in individual drinking pat- variability relate to use of dirty tanks and the 2 brated polyester and fiberglass tank (diam- terns. In addition, if the concentration of addition of pH-modifying ­substances.7 the active ingredient fails to be homogenous eter 65 cm, height 100 cm) filled with water at all times, both in the water tank and in Considering the risks described by these to 300 L. Neither predilutions nor final solu- the drinking troughs it supplies, individual authors in connection with orally adminis- tions were stirred after preparation during overdosing or underdosing can easily occur, tered products, this study attempts to verify, the entire experiment. The doses tested for depending on distance of troughs from the under field conditions, the stability and each product, specified in Table 2, are those water tank and the time of day at which the homogeneity of concentrations of NSAIDs established to treat 50-kg pigs that drink 5 L animal drinks. Hence, it is essential that marketed in Europe as oral solutions or sol- of water a day. The water used in this trial the medication administered by this route uble powders and administered to finisher was obtained from the water supply network be homogeneously dissolved in order to pigs in drinking ­water. of the city of Banyoles (Girona, Spain). minimize the variability inherent to this Water was characterized as hard (758 mg administration ­route. Materials and ­methods CaCO3 per L), pH 7.66, with free residual While medication administered through The solubilities of five oral NSAIDs mar- chlorine and combined residual chlorine of drinking water has great advantages, it also keted in Europe for use in pigs were com- 0.3 mg per L and < 0.02 mg per L, respec- has disadvantages, including possible lack of pared. The description of tested products tively. Water temperature was maintained at solubility or stability of the drugs in differ- is detailed in Table 1. In order to simulate 20ºC throughout the ­trial. 1 ent types of water. Regulations in Europe product administration under field condi- In order to assess the homogeneity of for licensing of veterinary medicinal prod- tions, a solution of each product was pre- the mixture prepared in the tank, 60-mL ucts stipulate that products administered in pared in a 300-L farm tank. Administration duplicate samples were obtained at three the drinking water must be proven soluble via dilution in bulk water tanks could be tank depths: lower, middle, and upper. For in both hard and soft water at temperatures considered the worst case, compared with minimal interference during the sampling from 4° to 20°C and must remain stable the much smaller and more readily managed process, a plastic probe (diameter 0.5 cm) for 24 hours, which is the optimal period volumes of concentrated stock solutions was attached to a 100-cm long rigid plastic of administration while maintaining the administered via proportioners. Active- rod that was marked at 5-cm intervals. Sam- hygienic quality of ­water.3 ingredient concentrations were obtained by ples were collected by placing the rod on the In 2005, KuKanich et al4 reported the sampling at three tank depths, lower, middle, tank bottom with the probe end attached at importance of both the formulation and the and upper, at 5 minutes, 12 hours, and 24 the desired depth. A syringe attached to the

Journal of Swine Health and Production — Volume 20, Number 6 271 probe at the water surface was used to aspi- of acetylsalicylic acid (ASA) [Sigma Aldrich, ANOVA performed in SigmaStat (version rate the sample. The first aspirated water was St Louis, Missouri]) made up to 25 mL with 2.03, 1992-1997; SPSS Inc, Ashburn, Vir- discarded to avoid contamination with water methanol, or 0.025 g of ketoprofen (Sigma ginia) was used to compare the concentra- from other ­levels. Aldrich) made up to 25 mL with HPLC tions (percentages) obtained at the three time points (stability) and at the three mea- Samples were obtained as follows: lower-depth mobile phase. After solution S1 was prepared, surement depths (homogeneity). Statistical sample at 5 cm from the bottom of the tank, a second dilution (S2) was prepared by mak- significance was set at ­< .05. middle-depth sample at 45 cm from the bot- ing 1 mL of solution S1 up to 50 mL with P tom, and upper-depth sample at 90 cm from HPLC mobile phase. Each water sample was the bottom (10 cm below the water surface). passed through a filter (diameter 0.45 μm) Results In order to assess homogeneity and stability for and injected with the corresponding standard Concentrations of the active ingredient 24 hours, samples were collected serially at 5 solution (S2) into the chromatograph. The in each product, expressed in mg per L of minutes (initial time) and at 12 and 24 hours chromatographic conditions for each product drinking water and as the percentage of after preparation of medicated­w ater. are described in Table 3.­ the calculated concentration, are shown in Table 4. Figure 1 shows that homogeneity of Medicated water samples were analyzed by Statistical ­analysis the active ingredients differed with sampling high-performance liquid chromatography In order to compare dispersion among the location in the tank. Five minutes after (HPLC) using validated techniques and with tested products, the concentration value preparation of medicated water, concentra- a limit of quantitation set at 10 mg per L. obtained for each product was expressed as tions at the lower part of the tank exceeded Standards were prepared by first preparing a percentage of the expected (calculated) the calculated values for all products except solution S1 (0.025 g of paracetamol [Alfa concentration, and this percentage was ketoprofen, ranging between an excess of Aesar, Ward Hill, Massachusetts] or 0.025 g used in the statistical analysis. A two-tailed 29% for paracetamol solution and 47% for

Table 1: Swine NSAID products tested for stability and homogeneity when prepared in drinking water at their therapeutic doses*

Product† Declared composition Dosage form Active ingredient Excipients Ketoprofen Ketoprofen 300 mg/mL Arginin, benzyl , water Oral solution Sodium salicylate Sodium salicylate 100% None Soluble powder Paracetamol powder Paracetamol 200 mg/g Lactose monohydrate Soluble powder Paracetamol solution Paracetamol 200 mg/mL Macrogol 300 Oral solution Acetylsalicylic acid Acetylsalicylic acid 100% None Soluble powder

* The calculated dose of each product was first diluted in 10 L of water in a plastic bucket without stirring. The contents of the bucket were then poured into a 300-L tank filled with water, without stirring. † Ketoprofen: Dinalgen/Danidol Oral Solution, Esteve veterinaria. Laboratorios Dr Esteve SA, Spain; sodium salicylate: Solacyl 100%, Eurovet Animal Health BV, the Netherlands; paracetamol powder: Pracetam Oral Powder, Sogeval Laboratoires, France; paracetamol solution: Pracetam Oral Solution, Sogeval Laboratoires, France; acetylsalicylic acid: ASA 100% Powder, Klat Chemie GmbH, Germany. NSAID = nonsteroidal anti-inflammatory drug.

Table 2: Quantities of each of five swine oral NSAID products added to 300 L of water in a stock tank*

Product# Therapeutic dose Target dosage for Quantity of product Concentration of active (mg/kg) 50-kg pig (mg) added to tank ingredient (mg/L) Ketoprofen 3 150 30 mL 30 Sodium salicylate 35 1750 105 g 350 Paracetamol powder 30 1500 450 g 300 Paracetamol solution 30 1500 450 mL 300 Acetylsalicylic acid 50 2500 150 g 500

* Products are described in Table 1. The concentration of each product in 300 L of water was based on the therapeutic dose of the active ingredient calculated to treat 50-kg pigs with a standard medicated-water consumption of 5 L per day. Each product was first diluted in 10 L of water in a bucket, without stirring; the contents of the bucket was then poured into the 300-L tank. NSAID = non-steroidal anti-inflammatory drug.

272 Journal of Swine Health and Production — November and December 2012 Table 3: Chromatographic conditions for analysis of active ingredients in five NSAID products labeled for treatment of swine in drinking water*

Active ingredient Paracetamol Sodium salicylate and Ketoprofen acetylsalicylic acid Volume (μL) 50 20 100 Mobile phase Phosphate buffer (75%), 0.01M (60%), Phosphate buffer pH 2.5 (60%), methanol (25%) methanol (40%) acetonitrile (40%) Flow rate (mL/minute) 1.0 1.0 1.0 Detector (nm) 245 280 233

* Medicated water samples were analyzed by high-performance liquid chromatography with a limit of quantitation of 10 mg/L of each active ingredient. The chromatography column in each case was a Waters Symmetry C18 (Waters, Milford, Massachusetts) μ(5 m) (3.9 × 150 mm). Each product was prepared in a 300-L tank to provide a dosage calculated for 50-kg pigs. Table 2 shows the calculated concentration of each active ingredient in the medicated water. NSAID = nonsteroidal anti-inflammatory drug.

Table 4: Active ingredient concentrations found in medicated drinking water after NSAID products were added to a 300-L tank and water was left unstirred*

Concentration of active ingredient (mg/L) (% of calculated concentration) P† Product 5 minutes 12 hours 24 hours Lower Middle Upper Lower Middle Upper Lower Middle Upper Time Depth 29.2 21.3 25.8 30.3 29.2 28.1 31.5 30.3 25.8 Ketoprofen .82 .28 (97.4) (71.2) (86.1) (101.1) (97.4) (93.6) (104.9) (101.1) (86.1) 510.1 300.0 58.4 498.9 395.5 118.0 482.0 280.9 137.1 Sodium salicylate .56 .002 (145.7) (85.7) (16.7) (142.5) (113.0) (33.7) (137.7) (80.3) (39.2) 434.8 246.1 91.0 468.5 240.4 125.8 438.2 220.2 127.0 Paracetamol powder .20 < .001 (144.9) (82.0) (30.3) (156.2) (80.1) (41.9) (146.1) (73.4) (42.3) 386.5 238.2 129.2 371.9 186.5 149.4 369.7 203.4 179.8 Paracetamol solution .70 < .001 (128.8) (79.4) (43.1) (124.0) (62.2) (49.8) (123.2) (67.8) (59.9) 737.1 325.8 289.9 783.1 370.8 415.7 415.7 359.6 374.2 Acetylsalicylic acid .45 .07 (147.4) (65.2) (58.0) (156.6) (74.2) (83.1) (83.1) (71.9) (74.8)

* NSAID products, calculated concentrations of active ingredients, and analytical methods are described in Tables 1-3. Samples were col- lected at 5 minutes, 12 hours, and 24 hours after products were added to the water, and at three different depths: Lower, 5 cm from the bottom; Middle, 45 cm from the bottom; Upper, 90 cm from the bottom (10 cm below the water surface). Height of the tank, 100 cm. † Statistical analysis was performed by ANOVA, with P < .05 considered statistically significant. NSAID = non-steroidal anti-inflammatory drug.

ASA (Figure 1A). This tendency to overdose The concentration at any of the measure- powder. Concentrations of ASA also varied in the lower part of the tank persisted at the ment levels (sampling depths) did not among sampling depths, but the differences 12-hour reading, with percentages ranging change significantly with time. However, were not statistically significant P( = .07). between an excess of 1% for ketoprofen and concentrations of all ASA samples collected The degree of dispersion of each product 57% for ASA (Figure 1B). At the 24-hour at 24 hours were below the calculated con- is depicted in Figure 2, which shows the reading, concentrations exceeded the centration, as shown in Figure ­1. concentrations obtained from the nine water calculated values by 46% for paracetamol samples analyzed for each product, regard- While no statistically significant differences powder, 38% for sodium salicylate, and less of sampling ­time. 23% for paracetamol solution (Figure 1C). were observed among the five products, Concentration of ketoprofen exceeded statistically significant differences among the calculated value by only 5%, while the three sampling depths were detected Discussion concentration of ASA was only 83% of the in concentrations of sodium salicylate, Because no significant time-related differ- ences were observed, all products apparently calculated ­value. paracetamol solution, and paracetamol Journal of Swine Health and Production — Volume 20, Number 6 273 Figure 1: Active ingredient, as a percentage of the calculated concentration of each product, at three sampling depths in a 300-L water tank (1 m height) 5 minutes (A), 12 hours (B), and 24 hours (C) after five NSAID products were each mixed with water (products and protocols described in Tables 1 and 2, respectively). Sampling depth: Upper, 10 cm below water surface, 90 cm from the bottom of the tank; Middle, 45 cm from the bottom; and Lower, 5 cm from the bottom. Calculated concentra- tion (100%) is represented by a black circle.

A 5 minutes B 12 hours

Upper Upper

Middle Middle

Zone of water tank of water Zone Lower tank of water Zone Lower

Ketoprofen Ketoprofen Sodium salicylate Sodium salicylate ParacetamolParacetamol powder Acetylsalicylic solution acid ParacetamolParacetamol powder Acetylsalicylic solution acid

C 24 hours

Upper

Middle

Zone of water tank of water Zone Lower

Ketoprofen Sodium salicylate ParacetamolParacetamol powder Acetylsalicylic solution acid showed acceptable stability in drinking and paracetamol solution, concentrations of active ingredient would be consumed. water. However, all ASA samples collected increased significantly with increasing Therefore, an underdose might also occur if at 24 hours were below the calculated con- sampling depth. Under field conditions in an individual animal drinks water late in the centration, which might suggest that degra- Europe, the water distribution pipe usually day, thus increasing the possibility of lack of dation of the active ingredient had occurred. takes the water from the lower part of the efficacy. In the case of ASA, the absence of Inserts of several commercial ASA products tank, thus results obtained at this depth significant differences at different sampling recently registered support this by stating are particularly important. The high values depths, despite its apparent high dispersion that the stability of the product in drinking found at this depth of the tank forewarned at the 5-minute and 12-hour time points, water is 12 ­hours.8-10 that up to a 50% overdose might be reached, may be due to excessive variability for such a thereby increasing the risk of adverse events limited number of analyzed samples. Overall Significant differences were detected in and violative residues in the carcasses. On results showed that ketoprofen had the best the sampling-depth variable for all prod- the other hand, as the overdosed water is dissolution and lowest variability among all ucts except ketoprofen and ASA. For consumed during the day, at the end of tested ­products. sodium salicylate, paracetamol powder, the day water with lower concentration 274 Journal of Swine Health and Production — November and December 2012 References Figure 2: Variability observed (median and percentiles) in active ingredient as a 1. Vermeulen B, De Backer P, Remon JP. Drug percentage of the calculated concentration of samples of five NSAID products, administration to poultry. Adv Drug Del Rev. each diluted in water without stirring (products and protocols described in ­2002;54:795–803. Tables 1 and 2, respectively). Samples were collected at 5 minutes, 12 hours, and 2. Toutain PL, Lees P. WS04 The population 24 hours post administration at three depths in a 300-L water tank (nine samples PK/PD approach for a rational use of anti- per product): Upper, 10 cm below water surface (90 cm from the bottom of the infective drugs to minimize resistance. J Vet Pharmacol Ther. 2006;9(suppl 1):26–29. doi: tank); Middle, 45 cm from the bottom; and Lower, 5 cm from the bottom. Samples ­10.1111/j.1365–2885.2006.00773_4.x. were analyzed by high-performance liquid chromatography. 3. EMEA/CVMP/540/03 Rev 1: Guideline on Quality Aspects of Pharmaceutical Veterinary Medicines for Administration Via Drinking Water. 200 European Medicines Agency, Committee for Veterinary Medicinal Products, 2005. Available at: http://www.ema.europa.eu/docs/en_GB/docu- ment_library/Scientific_guideline/2009/10/ WC500004462.pdf. Accessed 10 August ­2012. 150 4. KuKanich B, Gehring R, Webb AI, Craigmill AL, Riviere JE. Effect of formulation and route of administration on tissue residues and withdrawal times. JAVMA. 2005;227:1574–1577.­ 5. Dorr PM, Nemechek MS, Scheidt AB, 100 Baynes RE, Gebreyes WA, Almond GW. Water-flow variation and pharmacoepidemiology of tetracycline hydrochloride administration via drinking water in swine finishing farms.JAVMA . ­2009;235:299–304. 6. Santos MD, Vermeersch H, Remon JP, 50 Schelkens M, De Backer P, Ducatelle R, Haeseb- rouck F. Administration of doxycycline hydrochlo- ride via drinking water to turkeys under laboratory and field conditions.Poult Sci. ­1997;76:1342–1348. 7. Dorr PM, Madson D, Wayne S, Scheidt AB, 0 Almond GW. Impact of pH modifiers and drug exposure on the solubility of pharmaceutical prod- ucts commonly administered through water delivery Ketoprofen systems. J Swine Health Prod. ­2009;17:217–222. Sodium salicylate 8. AEMPSa (Spanish Agency of Medicines and Actual versus calculated concentration of active ingredient (%) of active ingredient concentration calculated versus Actual Paracetamol powderParacetamol solutionAcetylsalicylic acid Sanitary Products) Summary of Product Character- istics document for Vetalgine [in Spanish]. Available at: https://sinaem4.agemed.es/consavet/ especialidad.do?metodo=verFichaWordPdf&cod igo=1913 ESP&formato=pdf&formulario=FICHAS. In general, no relevant differences were at all time points and sampling depths, Accessed 10 August ­2012. observed between soluble-powder formu- evidencing better homogeneity and stability 9. AEMPSb (Spanish Agency of Medicines and lations and oral solutions. However, the in drinking water. Thus ketoprofen might Sanitary Products) Summary of Product Character- istics document for Apirex [in Spanish]. Available better behavior of ketoprofen solubility be considered the gold standard when the at: https://sinaem4.agemed.es/consavet/ versus the other oral solution formulation, behavior of other currently available or especialidad.do?metodo=verFichaWordPdf&cod paracetamol solution, could be because the future NSAID products for drinking water igo=1969 ESP&formato=pdf&formulario=FICHAS. active ingredient of ketoprofen dissolves use are c­ ompared. Accessed 10 August ­2012. 10. AEMPSc (Spanish Agency of Medicines and in water, while paracetamol solution is dis- Sanitary Products) Summary of Product Character- solved in the excipient, a polyethylene glycol Implications istics document for Fatrospirina [in Spanish]. Avail- derivative, which in turn must dissolve when able at: https://sinaem4.agemed.es/consavet/ • The use of NSAIDs in drinking water especialidad.do?metodo=verFichaWordPdf&cod the product is added to water. In the case of for treatment of farm animals can result igo=1878 ESP&formato=pdf&formulario=FICHAS. the ketoprofen product, the active ingredient in overdosing or underdosing when the Accessed 10 August ­2012. is already diluted in water, and thus imme- concentration of drug varies in different diately dissolves in the whole tank volume. areas of the ­tank. It is likely that thoroughly stirring the tank • Overdosing may increase the risk of water after product addition would have adverse events and violative residues in been advantageous for the other products. the carcasses, while lack of efficacy may In this trial, however, products were added occur when a product is ­underdosed. without stirring in order to simulate the • Lack of homogeneity is more evident most unfavorable and authentic conditions when the added product is a soluble on a commercial farm. The need for stirring powder rather than a so­ lution. is not mentioned in the instructions for use (labeling) of any of the products ­tested. Concentrations of ketoprofen most closely approached the calculated concentration

Journal of Swine Health and Production — Volume 20, Number 6 275